Cite
Tolerance of glucocorticoids in giant cell arteritis: a study of patient-reported adverse events.
MLA
de Boysson, Hubert, et al. “Tolerance of Glucocorticoids in Giant Cell Arteritis: A Study of Patient-Reported Adverse Events.” Rheumatology (Oxford, England), vol. 61, no. 9, Aug. 2022, pp. 3567–75. EBSCOhost, https://doi.org/10.1093/rheumatology/keab921.
APA
de Boysson, H., Barakat, C., Dumont, A., Boutemy, J., Martin Silva, N., Maigné, G., Nguyen, A., Lavergne, A., Castan, P., Gallou, S., Sultan, A., Deshayes, S., & Aouba, A. (2022). Tolerance of glucocorticoids in giant cell arteritis: a study of patient-reported adverse events. Rheumatology (Oxford, England), 61(9), 3567–3575. https://doi.org/10.1093/rheumatology/keab921
Chicago
de Boysson, Hubert, Clivia Barakat, Anael Dumont, Jonathan Boutemy, Nicolas Martin Silva, Gwénola Maigné, Alexandre Nguyen, et al. 2022. “Tolerance of Glucocorticoids in Giant Cell Arteritis: A Study of Patient-Reported Adverse Events.” Rheumatology (Oxford, England) 61 (9): 3567–75. doi:10.1093/rheumatology/keab921.